12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Company News  |  Other News

Genmab cancer news

Genmab announced a revised corporate strategy that includes plans to reduce operating expenses by 20% in 2011 through a reduction in R&D spending. As part of the R&D reductions, Genmab...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >